Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$38.25 - $52.62 $48,960 - $67,353
-1,280 Reduced 6.55%
18,270 $714,000
Q2 2022

Aug 09, 2022

BUY
$35.1 - $66.01 $21,411 - $40,266
610 Added 3.22%
19,550 $799,000
Q1 2022

May 10, 2022

BUY
$57.43 - $71.39 $49,389 - $61,395
860 Added 4.76%
18,940 $1.24 Million
Q4 2021

Feb 11, 2022

BUY
$63.4 - $87.14 $157,232 - $216,107
2,480 Added 15.9%
18,080 $1.26 Million
Q3 2021

Nov 12, 2021

BUY
$69.28 - $84.46 $27,019 - $32,939
390 Added 2.56%
15,600 $1.09 Million
Q2 2021

Aug 12, 2021

BUY
$64.13 - $80.18 $77,597 - $97,017
1,210 Added 8.64%
15,210 $1.21 Million
Q1 2021

May 14, 2021

BUY
$53.79 - $66.98 $753,060 - $937,720
14,000 New
14,000 $917,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.9B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Cna Financial Corp Portfolio

Follow Cna Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cna Financial Corp with notifications on news.